Bringing the fundamentals into focus…
Back to Regeneron Pharmaceuticals, Inc.
How Regeneron Pharmaceuticals, Inc. stacks up
REGN · against 1,335 other Healthcare companies
Profitability
85/ 100
Near the top of its peers.
Ranked #195 of 1,336 · scores higher than 85% of peers
Bars: peers in each 10-point band of the profitability score133 peers with a profitability score of 80–89, including REGN · Click a bar to see the companies
Why profitability scores 85?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its return on assets, operating margin and return on invested capital, which are stronger than most Healthcare peers.
- a higher return on invested capital: stronger than 67% of peers. Return on invested capital: 9.7% vs peer median 4.7%
- a wider operating margin: stronger than 88% of peers. Operating margin: 24.7% vs peer median 7.1%
- a higher return on assets: stronger than 91% of peers. Return on assets: 10.4% vs peer median 1.7%
Metric by metric
Position: dot = REGN, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | REGN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | 9.7% | 4.7% | 67% | 33% | |
| Operating marginHigher is better · 1,251 reported | 24.7% | 7.1% | 88% | 33% | |
| Return on assetsHigher is better · 1,315 reported | 10.4% | 1.7% | 91% | 33% | |
| Return on equityHigher is better · 1,252 reported | 14.0% | 3.2% | 81% | Context only | |
| Gross marginHigher is better · 1,394 reported | 44.5% | 45.9% | 49% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around REGN| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 195 | 58.6B USD | 85 | 52 | |
| 195 | 494.7B INR (≈$5.9B) | 85 | 70 | |
| 195 | 1.26T INR (≈$15.1B) | 85 | 63 | |
| 195 | 5.0B SEK (≈$497M) | 85 | 61 | |
| 195 | 100.2B USD | 85 | 68 | |
| 195 | 4.6B USD | 85 | 61 | |
| 208 | 43.30T KRW (≈$31.2B) | 84 | 68 | |
| 208 | 3.5B CNY (≈$491M) | 84 | 79 | |
| 208 | 37.3B HKD (≈$4.8B) | 84 | 90 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score